查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1513887

胰岛素输送系统的全球市场

Insulin Delivery Systems
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 272 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球胰岛素输送系统市场预计将达到 168 亿美元

2023年全球胰岛素输送系统市场预计为134亿美元，预计到2030年将达到168亿美元，2023-2030年分析期间复合年增长率为3.3%。注射器是本报告分析的细分市场之一，预计复合年增长率为 3.4%，到分析期结束时将达到 70 亿美元。分析期内，钢笔细分市场的复合年增长率预计为 4.3%。

美国市场预估36亿美元，中国预估复合年增率5.8%

预计 2023 年美国胰岛素输送系统市场规模将达 36 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达34亿美元，2023-2030年分析期间复合年增长率为5.8%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 0.6% 和 4.0%。在欧洲，德国的复合年增长率预计为 1.4%。

胰岛素输送系统 - 主要趋势和驱动因素

胰岛素输送系统是糖尿病治疗的重要组成部分，糖尿病是一种影响全世界数百万人的慢性疾病。这些系统旨在以受控且有效的方式输送胰岛素（一种调节血糖值所需的荷尔蒙）。胰岛素输送系统有许多不同类型，包括注射器、胰岛素笔、胰岛素帮浦和吸入胰岛素等新方法。这些系统在便利性、准确性和使用者体验方面都列出了不同的优势。例如，胰岛素笔是许多患者的热门选择，因为它们是预填充且易于携带的。胰岛素帮浦对第 1 型糖尿病患者特别有益，因为它们可以持续分泌接近人体自然胰岛素分泌的胰岛素。随着医疗技术的进步和对患者需求的深入了解，情况正在不断发展。

科技创新是胰岛素输送系统进步的主要驱动力。现代胰岛素帮浦具有先进的功能，例如连续血糖监测 (CGM) 整合、自动胰岛素剂量 (AID) 和智慧型手机连接。这些进步使得糖尿病管理更加精确和个人化，降低低血糖风险并改善整体血糖控制。此外，可以追踪剂量并提供提醒的智慧胰岛素笔的开发有助于解决药物依从性和剂量准确性问题。吸入式胰岛素的采用为注射提供了一种非侵入性的替代方案，对不喜欢针头的患者很有吸引力。此外，研究正在进展到闭合迴路系统，也称为人工胰臟系统，其目标是创建全自动胰岛素输送解决方案，同时最大限度地减少患者干预。这些技术创新不仅改善了糖尿病患者的生活质量，也为糖尿病治疗树立了新标准。

胰岛素输送系统市场的成长受到多种因素的推动，例如糖尿病盛行率的增加、技术的进步以及糖尿病管理意识的提高。由于肥胖和久坐的生活方式等因素，糖尿病（尤其是第 2 型糖尿病）盛行率不断上升，大大扩大了对高效且易于使用的胰岛素输送解决方案的需求。技术的进步使这些系统更容易使用和有效，吸引了更广泛的患者群体。行动应用程式和云端基础的资料管理等数位健康技术的整合正在增强患者的参与度和对治疗通讯协定的遵守。消费者的行为也在发生变化，强调便利性和侵入性较小的选择，推动了智慧笔和吸入胰岛素等创新输送方法的采用。此外，旨在改善糖尿病治疗基础设施的政府支持政策和倡议正在推动市场成长。竞争格局的特点是高科技公司和医疗保健提供者之间的合作，进一步加速创新和市场渗透。总体而言，在人口趋势、技术进步和不断变化的患者偏好的共同推动下，胰岛素输送系统市场预计将显着扩大。

调查企业举例（共32家）

  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Insulet Corporation
  • Medtronic, Inc.
  • Novo Nordisk A/S
  • Wockhardt Ltd.
  • Ypsomed AG

目录

第一章调查方法

第二章执行概述

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 欧洲其他地区
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP-6283

Global Insulin Delivery Systems Market to Reach US$16.8 Billion by 2030

The global market for Insulin Delivery Systems estimated at US$13.4 Billion in the year 2023, is expected to reach US$16.8 Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2023-2030. Syringes, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$7.0 Billion by the end of the analysis period. Growth in the Pens segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.6 Billion While China is Forecast to Grow at 5.8% CAGR

The Insulin Delivery Systems market in the U.S. is estimated at US$3.6 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.4 Billion by the year 2030 trailing a CAGR of 5.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.6% and 4.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.4% CAGR.

Insulin Delivery Systems - Key Trends and Drivers

Insulin delivery systems are a critical component in the management of diabetes, a chronic condition affecting millions of people worldwide. These systems are designed to administer insulin, a hormone necessary for regulating blood glucose levels, in a controlled and efficient manner. There are various types of insulin delivery systems, including syringes, insulin pens, insulin pumps, and newer methods like inhalable insulin. Each of these systems offers different advantages in terms of convenience, precision, and user experience. Insulin pens, for example, are prefilled and easy to carry, making them a popular choice for many patients. Insulin pumps provide continuous insulin delivery, closely mimicking the body’s natural insulin release, which is particularly beneficial for individuals with type 1 diabetes. The landscape of insulin delivery systems is continuously evolving, driven by advancements in medical technology and a deeper understanding of patient needs.

Technological innovation has been a significant driver in the advancement of insulin delivery systems. Modern insulin pumps are now equipped with advanced features such as continuous glucose monitoring (CGM) integration, automated insulin delivery (AID), and smartphone connectivity. These advancements allow for more precise and personalized diabetes management, reducing the risk of hypoglycemia and improving overall glycemic control. Additionally, the development of smart insulin pens, which can track doses and provide reminders, is helping to address issues related to adherence and dosing accuracy. The introduction of inhalable insulin offers a non-invasive alternative to injections, appealing to patients who are needle-averse. Furthermore, research into closed-loop systems, also known as artificial pancreas systems, is ongoing, with the goal of creating fully automated insulin delivery solutions that require minimal patient intervention. These innovations are not only improving the quality of life for diabetes patients but are also setting new standards in diabetes care.

The growth in the insulin delivery systems market is driven by several factors, including the increasing prevalence of diabetes, technological advancements, and a growing awareness of diabetes management. The rising incidence of diabetes particularly type 2 diabetes, due to factors such as obesity and sedentary lifestyles, has significantly expanded the demand for efficient and user-friendly insulin delivery solutions. Technological advancements have made these systems more accessible and effective, attracting a broader patient base. The integration of digital health technologies, such as mobile apps and cloud-based data management, is enhancing patient engagement and adherence to treatment protocols. Consumer behavior is also shifting, with a greater emphasis on convenience and minimally invasive options, driving the adoption of innovative delivery methods like smart pens and inhalable insulin. Additionally, supportive government policies and initiatives aimed at improving diabetes care infrastructure are facilitating market growth. The competitive landscape is marked by collaborations between tech companies and healthcare providers, further accelerating innovation and market penetration. Overall, the insulin delivery systems market is poised for significant expansion, propelled by a combination of demographic trends, technological progress, and evolving patient preferences.

Select Competitors (Total 32 Featured) -

  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Insulet Corporation
  • Medtronic, Inc.
  • Novo Nordisk A/S
  • Wockhardt Ltd.
  • Ypsomed AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Insulin Delivery Systems - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Diabetes Throws the Spotlight on Insulin Delivery Systems
    • Technological Advancements Propel Growth in Smart Insulin Delivery Devices
    • Increasing Adoption of Continuous Glucose Monitoring (CGM) Systems Expands Addressable Market Opportunity
    • Integration of Digital Health Technologies Strengthens Business Case for Advanced Insulin Delivery Solutions
    • Development of Automated Insulin Delivery (AID) Systems Boost Innovation
    • Non-Invasive Delivery Methods, Such as Inhalable Insulin, Drive Adoption among Needle-Averse Patients
    • Enhanced Smartphone Connectivity and Mobile App Integration Spurs Growth in User Engagement
    • Personalized Diabetes Management Generates Demand for Customized Insulin Delivery Solutions
    • Research into Closed-Loop Systems and Artificial Pancreas Technology Throws the Spotlight on Future Trends
    • Increased Focus on Minimally Invasive Options Expands Addressable Market Opportunity
    • Consumer Shift towards Convenience and Ease of Use Drives Adoption of Innovative Insulin Delivery Methods
    • Enhanced Data Management and Cloud-Based Solutions Generates Demand for Integrated Insulin Delivery Systems
    • Rising Incidence of Type 2 Diabetes among Younger Populations Influences Market Dynamics
    • Improving Quality of Life for Diabetes Patients Sustains Growth in Advanced Insulin Delivery Technologies
    • Evolution of Smart Insulin Pens and Dose Tracking Technologies Strengthens Business Case for Precision Medicine
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Insulin Delivery Systems Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Insulin Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Insulin Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Insulin Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Syringes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Pens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Pens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Pen needles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Pen needles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Pen needles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Jet Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Jet Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Jet Injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Homecare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Homecare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Homecare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Ambulatory Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Ambulatory Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Ambulatory Care Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • JAPAN
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • CHINA
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • EUROPE
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Insulin Delivery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Insulin Delivery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Insulin Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • FRANCE
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: France 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • GERMANY
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Spain 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Russia 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Insulin Delivery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Insulin Delivery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Insulin Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Australia 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • INDIA
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 122: India Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: India 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 125: India Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: India 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: South Korea 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Insulin Delivery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Insulin Delivery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Insulin Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Argentina 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Brazil 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Mexico 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Rest of Latin America 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Insulin Delivery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Insulin Delivery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Insulin Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Iran 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Israel 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Saudi Arabia 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: UAE 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Rest of Middle East 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • AFRICA
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Africa 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030

IV. COMPETITION